Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance.

Osteoporos Int. 2019 Nov 6. doi: 10.1007/s00198-019-05181-6.

Berencsi K, Sami A, Ali MS, Marinier K, Deltour N, Perez-Guthann S, Pedersen L, Rijnbeek P, Van der Lei J, Lapi F, Simonetti M, Reyes C, Sturkenboom MCJM, Prieto-Alhambra D.

https://www.ncbi.nlm.nih.gov/pubmed/31696274.
Patrocinadores de la web
Lilly
Angelini
Laboratorios Rubió
Grupo Italfármaco
UCB-Pharma
Theramex
Stada
Gedeon Richter
Kyowa Kirin
Amgen